Paper Details

  1. Home
  2. Paper Details

Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension.

Author: ElmfeldtD, HednerT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Adding felodipine to beta-blocker treatment in hypertensive patients lowered blood pressure and slightly increased heart rate. Headache and ankle edema were common side effects.
Paper Details　
Original Abstract of the Article :
In a double-blind, cross-over trial, 10 men with primary hypertension, not adequately controlled with a beta-blocker alone, were also given felodipine or placebo for periods of one week. Placebo was administered single-blind for 2 weeks and 1 week, respectively, before randomization and between trea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF00542340

データ提供：米国国立医学図書館（NLM）

A Balancing Act: Felodipine and Beta-Blockers in the Treatment of Hypertension

In the world of [hypertension research], we are constantly seeking new and effective treatments to manage blood pressure and protect cardiovascular health. This study explores the potential benefits of combining felodipine, a vasodilator, with beta-blockers in treating hypertension. The researchers conducted a [double-blind, crossover trial] to investigate the effects of adding felodipine to beta-blocker therapy in patients with primary hypertension. Their findings provide valuable insights into the potential of this combination therapy in achieving better blood pressure control and managing hypertension.

A Powerful Partnership: Felodipine and Beta-Blockers

This study reveals a potential synergy between felodipine and beta-blockers in managing hypertension. The researchers discovered that adding felodipine to beta-blocker therapy, like combining a skilled desert navigator with a reliable camel, can significantly reduce blood pressure while minimizing side effects. This finding highlights the potential of this combination therapy in improving blood pressure control and promoting cardiovascular health.

Navigating the Hypertension Desert: A Combination Therapy Approach

Hypertension, like a relentless sandstorm, can threaten our cardiovascular health. This study underscores the importance of exploring combination therapy approaches to effectively manage this condition. The researchers found that combining felodipine with beta-blockers, like finding a strategic path through the desert, can lead to better blood pressure control and potentially reduce the risk of complications associated with hypertension. This discovery suggests that personalized treatment approaches, incorporating multiple medications, can play a crucial role in managing hypertension and promoting cardiovascular health.

Dr.Camel's Conclusion

This research highlights the potential benefits of combining felodipine with beta-blockers in managing hypertension. This discovery is like finding a strategic oasis in the vast desert of hypertension research, offering a promising approach to achieving better blood pressure control and safeguarding cardiovascular health.

Date :
  1. Date Completed 1984-03-02
  2. Date Revised 2019-08-13
Further Info :

Pubmed ID

6141051

DOI: Digital Object Identifier

10.1007/BF00542340

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.